Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...

Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the ...

As at end-2023, at least 25 RNA-based therapies had been approved by the US Food and Drug Administration to target infectious diseases, rare genetic diseases and high cholesterol, DPM Heng said.

The molecule was found in soil samples collected from a laboratory technician’s garden. The discovery shows that “there is ...

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp (a) inhibitor from China's Jiangsu Hengrui ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...